S100A8/A9 as a central hub in inflammaging: Cross-system mechanisms
Ageing Research Reviews · 2026-06 · 118 · 103108
DOI: 10.1016/j.arr.2026.103108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-06. Verfasst von Shiyu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China; Institute for…. Hauptthemen laut MEDLINE: Calgranulin B, Calgranulin A, Inflammation, Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 225 Literaturangaben. Gefördert von: Shanghai Municipality Science and Technology Commission, Shanghai Science and Technology Development Foundation, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Global population aging intensifies "inflammaging," a bidirectional link between chronic inflammation and aging-related pathology. Among them, S100A8/A9 forms a positive feedback loop of "aging-inflammation". Here, we systematically review the structure and function of S100A8/A9, including extracellularly promoting leukocyte adhesion and myeloid-derived suppressor cell aggregation, and intracellularly regulating NOD-like receptor protein 3 inflammasome, arachidonic acid metabolism, autophagy, and apoptosis. This review systematically examines system-specific roles of S100A8/A9: in tumors, it fosters immunosuppression and chemoresistance; in the nervous system, it fuels neuroinflammation and neuronal injury via neutrophil extracellular traps and ferroptosis; in the cardiovascular system, it accelerates endothelial aging and plaque instability; in metabolism, it drives adipose dysfunction and insulin resistance; and in muscle, it induces atrophy and frailty. Disease activity, S100A8/A9 expression levels, chemotherapy resistance, and poor prognosis can be used as biomarkers for early diagnosis, risk stratification, and imaging tracing. Accumulating evidence demonstrates robust correlations between elevated S100A8/A9 expression, therapeutic resistance, and adverse clinical outcomes, establishing its utility as a diagnostic biomarker for disease stratification and molecular imaging. Targeting the S100A8/A9-Toll-like receptor 4 axis or neutralizing S100A9 strategies have shown potential in animal models to reduce inflammation and delay disease progression. In conclusion, S100A8/A9 is a core molecule connecting aging, inflammation, and multi-system lesions. Interventions targeting its pathway are expected to provide new strategies for extending healthy lifespans and a theoretical basis for novel and practical anti-aging strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China; Institute for Interdisciplinary Medicine Sciences, Shanghai University of Tradition…
- Institute for Interdisciplinary Medicine Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: zhoumm368@163.com.
- Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200082, China. Electronic address: chengzhao_79@163.com.
Förderung
- Shanghai Municipality Science and Technology Commission
- Shanghai Science and Technology Development Foundation
- Natural Science Foundation of Shanghai Municipality
- Shanghai Municipal Health Commission
Zitieren
APA
Wang, S., Ni, Y., Feng, J., Zhang, W., Zhou, M., & Zhao, C. (2026). S100A8/A9 as a central hub in inflammaging: Cross-system mechanisms. Ageing Research Reviews, 118, 103108. https://doi.org/10.1016/j.arr.2026.103108
Vancouver
Wang S, Ni Y, Feng J, Zhang W, Zhou M, Zhao C. S100A8/A9 as a central hub in inflammaging: Cross-system mechanisms. Ageing Research Reviews. 2026;118:103108. doi:10.1016/j.arr.2026.103108
BibTeX
@article{Wang2026,
author = {Wang, Shiyu and Ni, Yiming and Feng, Jiawei and Zhang, Wei and Zhou, Mingmei and Zhao, Cheng},
title = {S100A8/A9 as a central hub in inflammaging: Cross-system mechanisms},
journal = {Ageing Research Reviews},
year = {2026},
volume = {118},
pages = {103108},
doi = {10.1016/j.arr.2026.103108}
}
EUVIMED